Advertisement

Index by author

April 01, 2000; Volume 28,Issue 4

A

  1. Abraham, Trent L.

    1. Metabolism and Disposition of Moxonidine in Fischer 344 Rats
      Minxia M. He, Trent L. Abraham, Thomas J. Lindsay, Sylvia H. Chay, Boris A. Czeskis and Lisa A. Shipley
      Drug Metabolism and Disposition April 2000, 28 (4) 446-459;

  2. Anders, M.W.

    1. Porcine Kidney Microsomal Cysteine S-ConjugateN-Acetyltransferase-CatalyzedN-Acetylation of Haloalkene-Derived CysteineS-Conjugates
      Torsten Kraus, Viuita Uttamsingh, M.W. Anders and Sabine Wolf
      Drug Metabolism and Disposition April 2000, 28 (4) 440-445;

  3. Attolini, Laurence

    1. Oxidative Metabolism of Bupivacaine into Pipecolylxylidine in Humans Is Mainly Catalyzed by CYP3A
      Manon Gantenbein, Laurence Attolini, Bernard Bruguerolle, Pierre-Henri Villard, Franck Puyoou, Alain Durand, Bruno Lacarelle, Jean Hardwigsen and Yves-Patrice Le-Treut
      Drug Metabolism and Disposition April 2000, 28 (4) 383-385;

B

  1. Baker, David S.

    1. Pharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer Patients
      John Greg Slatter, Larry J. Schaaf, James P. Sams, Kenneth L. Feenstra, Mark G. Johnson, Paul A. Bombardt, Karen Sue Cathcart, Michael T. Verburg, Laura K. Pearson, Linda D. Compton, Langdon L. Miller, David S. Baker, Caroline V. Pesheck and Raymond S. Lord
      Drug Metabolism and Disposition April 2000, 28 (4) 423-433;

  2. Barthen, Mary T.

    1. The Synthesis, In Vitro Reactivity, and Evidence for Formation in Humans of 5-Phenyl-1,3-oxazinane-2,4-dione, a Metabolite of Felbamate
      Charles D. Thompson, Thomas A. Miller, Mary T. Barthen, Christine M. Dieckhaus, R. Duane Sofia and Timothy L. Macdonald
      Drug Metabolism and Disposition April 2000, 28 (4) 434-439;

  3. Bayse, Gladys S.

    1. The N-Acetylation of Arsanilic Acid In Vitro by Mammalian Enzymes
      Gladys S. Bayse, Laide A. Jinadu, Kiana L. Shaw and Kelita L. Wiley
      Drug Metabolism and Disposition April 2000, 28 (4) 487-492;

  4. Benoit, Etienne

    1. Thioesterification of 2-Arylpropionic Acids by Recombinant Acyl-Coenzyme A Synthetases (ACS1 and ACS2)
      Cendrine Sevoz, Etienne Benoit and Thierry Buronfosse
      Drug Metabolism and Disposition April 2000, 28 (4) 398-402;

  5. Blanco, Javier G.

    1. Human Cytochrome P450 Maximal Activities In Pediatric versus Adult Liver
      Javier G. Blanco, Patricia L. Harrison, William E. Evans and Mary V. Relling
      Drug Metabolism and Disposition April 2000, 28 (4) 379-382;

  6. Bombardt, Paul A.

    1. Pharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer Patients
      John Greg Slatter, Larry J. Schaaf, James P. Sams, Kenneth L. Feenstra, Mark G. Johnson, Paul A. Bombardt, Karen Sue Cathcart, Michael T. Verburg, Laura K. Pearson, Linda D. Compton, Langdon L. Miller, David S. Baker, Caroline V. Pesheck and Raymond S. Lord
      Drug Metabolism and Disposition April 2000, 28 (4) 423-433;

  7. Bruguerolle, Bernard

    1. Oxidative Metabolism of Bupivacaine into Pipecolylxylidine in Humans Is Mainly Catalyzed by CYP3A
      Manon Gantenbein, Laurence Attolini, Bernard Bruguerolle, Pierre-Henri Villard, Franck Puyoou, Alain Durand, Bruno Lacarelle, Jean Hardwigsen and Yves-Patrice Le-Treut
      Drug Metabolism and Disposition April 2000, 28 (4) 383-385;

  8. Buckpitt, Alan R.

    1. Species Differences in The Regio- and Stereoselectivity of 1-Nitronaphthalene Metabolism
      Katherine C. Watt and Alan R. Buckpitt
      Drug Metabolism and Disposition April 2000, 28 (4) 376-378;

  9. Buronfosse, Thierry

    1. Thioesterification of 2-Arylpropionic Acids by Recombinant Acyl-Coenzyme A Synthetases (ACS1 and ACS2)
      Cendrine Sevoz, Etienne Benoit and Thierry Buronfosse
      Drug Metabolism and Disposition April 2000, 28 (4) 398-402;

C

  1. Cathcart, Karen Sue

    1. Pharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer Patients
      John Greg Slatter, Larry J. Schaaf, James P. Sams, Kenneth L. Feenstra, Mark G. Johnson, Paul A. Bombardt, Karen Sue Cathcart, Michael T. Verburg, Laura K. Pearson, Linda D. Compton, Langdon L. Miller, David S. Baker, Caroline V. Pesheck and Raymond S. Lord
      Drug Metabolism and Disposition April 2000, 28 (4) 423-433;

  2. Chay, Sylvia H.

    1. Metabolism and Disposition of Moxonidine in Fischer 344 Rats
      Minxia M. He, Trent L. Abraham, Thomas J. Lindsay, Sylvia H. Chay, Boris A. Czeskis and Lisa A. Shipley
      Drug Metabolism and Disposition April 2000, 28 (4) 446-459;

  3. Chen, I-Wu

    1. Route-Dependent Nonlinear Pharmacokinetics of a Novel HIV Protease Inhibitor: Involvement of Enzyme Inactivation
      Jiunn H. Lin, I-Wu Chen, Masato Chiba, Joy A. Nishime and Florencia A. deLuna
      Drug Metabolism and Disposition April 2000, 28 (4) 460-466;

  4. Chiba, Masato

    1. Route-Dependent Nonlinear Pharmacokinetics of a Novel HIV Protease Inhibitor: Involvement of Enzyme Inactivation
      Jiunn H. Lin, I-Wu Chen, Masato Chiba, Joy A. Nishime and Florencia A. deLuna
      Drug Metabolism and Disposition April 2000, 28 (4) 460-466;

  5. Compton, Linda D.

    1. Pharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer Patients
      John Greg Slatter, Larry J. Schaaf, James P. Sams, Kenneth L. Feenstra, Mark G. Johnson, Paul A. Bombardt, Karen Sue Cathcart, Michael T. Verburg, Laura K. Pearson, Linda D. Compton, Langdon L. Miller, David S. Baker, Caroline V. Pesheck and Raymond S. Lord
      Drug Metabolism and Disposition April 2000, 28 (4) 423-433;

  6. Czeskis, Boris A.

    1. Metabolism and Disposition of Moxonidine in Fischer 344 Rats
      Minxia M. He, Trent L. Abraham, Thomas J. Lindsay, Sylvia H. Chay, Boris A. Czeskis and Lisa A. Shipley
      Drug Metabolism and Disposition April 2000, 28 (4) 446-459;

D

  1. Dailey, Harry A.

    1. N-Methylprotoporphyrin Is a More Potent Inhibitor of Recombinant Human Than of Recombinant Chicken Ferrochelatase
      Jeremy T. Gamble, Harry A. Dailey and Gerald S. Marks
      Drug Metabolism and Disposition April 2000, 28 (4) 373-375;

  2. deLuna, Florencia A.

    1. Route-Dependent Nonlinear Pharmacokinetics of a Novel HIV Protease Inhibitor: Involvement of Enzyme Inactivation
      Jiunn H. Lin, I-Wu Chen, Masato Chiba, Joy A. Nishime and Florencia A. deLuna
      Drug Metabolism and Disposition April 2000, 28 (4) 460-466;

  3. Dieckhaus, Christine M.

    1. The Synthesis, In Vitro Reactivity, and Evidence for Formation in Humans of 5-Phenyl-1,3-oxazinane-2,4-dione, a Metabolite of Felbamate
      Charles D. Thompson, Thomas A. Miller, Mary T. Barthen, Christine M. Dieckhaus, R. Duane Sofia and Timothy L. Macdonald
      Drug Metabolism and Disposition April 2000, 28 (4) 434-439;

  4. Durand, Alain

    1. Oxidative Metabolism of Bupivacaine into Pipecolylxylidine in Humans Is Mainly Catalyzed by CYP3A
      Manon Gantenbein, Laurence Attolini, Bernard Bruguerolle, Pierre-Henri Villard, Franck Puyoou, Alain Durand, Bruno Lacarelle, Jean Hardwigsen and Yves-Patrice Le-Treut
      Drug Metabolism and Disposition April 2000, 28 (4) 383-385;

E

  1. Evans, William E.

    1. Human Cytochrome P450 Maximal Activities In Pediatric versus Adult Liver
      Javier G. Blanco, Patricia L. Harrison, William E. Evans and Mary V. Relling
      Drug Metabolism and Disposition April 2000, 28 (4) 379-382;

F

  1. Feenstra, Kenneth L.

    1. Pharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer Patients
      John Greg Slatter, Larry J. Schaaf, James P. Sams, Kenneth L. Feenstra, Mark G. Johnson, Paul A. Bombardt, Karen Sue Cathcart, Michael T. Verburg, Laura K. Pearson, Linda D. Compton, Langdon L. Miller, David S. Baker, Caroline V. Pesheck and Raymond S. Lord
      Drug Metabolism and Disposition April 2000, 28 (4) 423-433;

  2. Funae, Yoshihiko

    1. Prediction of in Vivo Drug-Drug Interactions between Tolbutamide and Various Sulfonamides in Humans Based on in Vitro Experiments
      Kanji Komatsu, Kiyomi Ito, Yukiko Nakajima, Shin-ichi Kanamitsu, Susumu Imaoka, Yoshihiko Funae, Carol E. Green, Charles A. Tyson, Noriaki Shimada and Yuichi Sugiyama
      Drug Metabolism and Disposition April 2000, 28 (4) 475-481;

  3. Fung, Ho-Leung

    1. Pharmacokinetics of a Model Organic Nitrite Inhalant and its Alcohol Metabolite in Rats
      William Kielbasa and Ho-Leung Fung
      Drug Metabolism and Disposition April 2000, 28 (4) 386-391;

G

  1. Gamble, Jeremy T.

    1. N-Methylprotoporphyrin Is a More Potent Inhibitor of Recombinant Human Than of Recombinant Chicken Ferrochelatase
      Jeremy T. Gamble, Harry A. Dailey and Gerald S. Marks
      Drug Metabolism and Disposition April 2000, 28 (4) 373-375;

  2. Gantenbein, Manon

    1. Oxidative Metabolism of Bupivacaine into Pipecolylxylidine in Humans Is Mainly Catalyzed by CYP3A
      Manon Gantenbein, Laurence Attolini, Bernard Bruguerolle, Pierre-Henri Villard, Franck Puyoou, Alain Durand, Bruno Lacarelle, Jean Hardwigsen and Yves-Patrice Le-Treut
      Drug Metabolism and Disposition April 2000, 28 (4) 383-385;

  3. Green, Carol E.

    1. Prediction of in Vivo Drug-Drug Interactions between Tolbutamide and Various Sulfonamides in Humans Based on in Vitro Experiments
      Kanji Komatsu, Kiyomi Ito, Yukiko Nakajima, Shin-ichi Kanamitsu, Susumu Imaoka, Yoshihiko Funae, Carol E. Green, Charles A. Tyson, Noriaki Shimada and Yuichi Sugiyama
      Drug Metabolism and Disposition April 2000, 28 (4) 475-481;

  4. Greenblatt, David J.

    1. In Vitro Biotransformation of Sildenafil (Viagra): Identification of Human Cytochromes and Potential Drug Interactions
      Jill S. Warrington, Richard I. Shader, Lisa L. von Moltke and David J. Greenblatt
      Drug Metabolism and Disposition April 2000, 28 (4) 392-397;

H

  1. Hardwigsen, Jean

    1. Oxidative Metabolism of Bupivacaine into Pipecolylxylidine in Humans Is Mainly Catalyzed by CYP3A
      Manon Gantenbein, Laurence Attolini, Bernard Bruguerolle, Pierre-Henri Villard, Franck Puyoou, Alain Durand, Bruno Lacarelle, Jean Hardwigsen and Yves-Patrice Le-Treut
      Drug Metabolism and Disposition April 2000, 28 (4) 383-385;

  2. Harrison, Patricia L.

    1. Human Cytochrome P450 Maximal Activities In Pediatric versus Adult Liver
      Javier G. Blanco, Patricia L. Harrison, William E. Evans and Mary V. Relling
      Drug Metabolism and Disposition April 2000, 28 (4) 379-382;

  3. He, Minxia M.

    1. Metabolism and Disposition of Moxonidine in Fischer 344 Rats
      Minxia M. He, Trent L. Abraham, Thomas J. Lindsay, Sylvia H. Chay, Boris A. Czeskis and Lisa A. Shipley
      Drug Metabolism and Disposition April 2000, 28 (4) 446-459;

I

  1. Imaoka, Susumu

    1. Prediction of in Vivo Drug-Drug Interactions between Tolbutamide and Various Sulfonamides in Humans Based on in Vitro Experiments
      Kanji Komatsu, Kiyomi Ito, Yukiko Nakajima, Shin-ichi Kanamitsu, Susumu Imaoka, Yoshihiko Funae, Carol E. Green, Charles A. Tyson, Noriaki Shimada and Yuichi Sugiyama
      Drug Metabolism and Disposition April 2000, 28 (4) 475-481;

  2. Ito, Kiyomi

    1. Prediction of In Vivo Drug-Drug Interactions Based on Mechanism-based Inhibition from In Vitro Data: Inhibition of 5-Fluorouracil Metabolism by (E)-5-(2-Bromovinyl)uracil
      Shin-ichi Kanamitsu, Kiyomi Ito, Haruhiro Okuda, Kenichiro Ogura, Tadashi Watabe, Kei Muro and Yuichi Sugiyama
      Drug Metabolism and Disposition April 2000, 28 (4) 467-474;
    2. Prediction of in Vivo Drug-Drug Interactions between Tolbutamide and Various Sulfonamides in Humans Based on in Vitro Experiments
      Kanji Komatsu, Kiyomi Ito, Yukiko Nakajima, Shin-ichi Kanamitsu, Susumu Imaoka, Yoshihiko Funae, Carol E. Green, Charles A. Tyson, Noriaki Shimada and Yuichi Sugiyama
      Drug Metabolism and Disposition April 2000, 28 (4) 475-481;

J

  1. Jinadu, Laide A.

    1. The N-Acetylation of Arsanilic Acid In Vitro by Mammalian Enzymes
      Gladys S. Bayse, Laide A. Jinadu, Kiana L. Shaw and Kelita L. Wiley
      Drug Metabolism and Disposition April 2000, 28 (4) 487-492;

  2. Johnson, Mark G.

    1. Pharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer Patients
      John Greg Slatter, Larry J. Schaaf, James P. Sams, Kenneth L. Feenstra, Mark G. Johnson, Paul A. Bombardt, Karen Sue Cathcart, Michael T. Verburg, Laura K. Pearson, Linda D. Compton, Langdon L. Miller, David S. Baker, Caroline V. Pesheck and Raymond S. Lord
      Drug Metabolism and Disposition April 2000, 28 (4) 423-433;

  3. Johnston, Thomas P.

    1. Pharmacokinetics, Biliary Excretion, and Tissue Distribution of Novel Anti-HIV Agents, Cosalane and Dihydrocosalane, in Sprague-Dawley Rats
      Kameswara R. Kuchimanchi, Chandrasekhar Udata, Thomas P. Johnston and Ashim K. Mitra
      Drug Metabolism and Disposition April 2000, 28 (4) 403-408;

K

  1. Kanamitsu, Shin-ichi

    1. Prediction of In Vivo Drug-Drug Interactions Based on Mechanism-based Inhibition from In Vitro Data: Inhibition of 5-Fluorouracil Metabolism by (E)-5-(2-Bromovinyl)uracil
      Shin-ichi Kanamitsu, Kiyomi Ito, Haruhiro Okuda, Kenichiro Ogura, Tadashi Watabe, Kei Muro and Yuichi Sugiyama
      Drug Metabolism and Disposition April 2000, 28 (4) 467-474;
    2. Prediction of in Vivo Drug-Drug Interactions between Tolbutamide and Various Sulfonamides in Humans Based on in Vitro Experiments
      Kanji Komatsu, Kiyomi Ito, Yukiko Nakajima, Shin-ichi Kanamitsu, Susumu Imaoka, Yoshihiko Funae, Carol E. Green, Charles A. Tyson, Noriaki Shimada and Yuichi Sugiyama
      Drug Metabolism and Disposition April 2000, 28 (4) 475-481;

  2. Kasahara, Mie

    1. Studies on the Cytochrome P450 (CYP)-Mediated Metabolic Properties of Miocamycin: Evaluation of the Possibility of a Metabolic Intermediate Complex Formation with CYP, and Identification of the Human CYP Isoforms
      Mie Kasahara, Hisashi Suzuki and Izumi Komiya
      Drug Metabolism and Disposition April 2000, 28 (4) 409-417;

  3. Kielbasa, William

    1. Pharmacokinetics of a Model Organic Nitrite Inhalant and its Alcohol Metabolite in Rats
      William Kielbasa and Ho-Leung Fung
      Drug Metabolism and Disposition April 2000, 28 (4) 386-391;

  4. Komatsu, Kanji

    1. Prediction of in Vivo Drug-Drug Interactions between Tolbutamide and Various Sulfonamides in Humans Based on in Vitro Experiments
      Kanji Komatsu, Kiyomi Ito, Yukiko Nakajima, Shin-ichi Kanamitsu, Susumu Imaoka, Yoshihiko Funae, Carol E. Green, Charles A. Tyson, Noriaki Shimada and Yuichi Sugiyama
      Drug Metabolism and Disposition April 2000, 28 (4) 475-481;

  5. Komiya, Izumi

    1. Studies on the Cytochrome P450 (CYP)-Mediated Metabolic Properties of Miocamycin: Evaluation of the Possibility of a Metabolic Intermediate Complex Formation with CYP, and Identification of the Human CYP Isoforms
      Mie Kasahara, Hisashi Suzuki and Izumi Komiya
      Drug Metabolism and Disposition April 2000, 28 (4) 409-417;

  6. Kraus, Torsten

    1. Porcine Kidney Microsomal Cysteine S-ConjugateN-Acetyltransferase-CatalyzedN-Acetylation of Haloalkene-Derived CysteineS-Conjugates
      Torsten Kraus, Viuita Uttamsingh, M.W. Anders and Sabine Wolf
      Drug Metabolism and Disposition April 2000, 28 (4) 440-445;

  7. Kuchimanchi, Kameswara R.

    1. Pharmacokinetics, Biliary Excretion, and Tissue Distribution of Novel Anti-HIV Agents, Cosalane and Dihydrocosalane, in Sprague-Dawley Rats
      Kameswara R. Kuchimanchi, Chandrasekhar Udata, Thomas P. Johnston and Ashim K. Mitra
      Drug Metabolism and Disposition April 2000, 28 (4) 403-408;

L

  1. Lacarelle, Bruno

    1. Oxidative Metabolism of Bupivacaine into Pipecolylxylidine in Humans Is Mainly Catalyzed by CYP3A
      Manon Gantenbein, Laurence Attolini, Bernard Bruguerolle, Pierre-Henri Villard, Franck Puyoou, Alain Durand, Bruno Lacarelle, Jean Hardwigsen and Yves-Patrice Le-Treut
      Drug Metabolism and Disposition April 2000, 28 (4) 383-385;

  2. Le-Treut, Yves-Patrice

    1. Oxidative Metabolism of Bupivacaine into Pipecolylxylidine in Humans Is Mainly Catalyzed by CYP3A
      Manon Gantenbein, Laurence Attolini, Bernard Bruguerolle, Pierre-Henri Villard, Franck Puyoou, Alain Durand, Bruno Lacarelle, Jean Hardwigsen and Yves-Patrice Le-Treut
      Drug Metabolism and Disposition April 2000, 28 (4) 383-385;

  3. Lin, Jiunn H.

    1. Route-Dependent Nonlinear Pharmacokinetics of a Novel HIV Protease Inhibitor: Involvement of Enzyme Inactivation
      Jiunn H. Lin, I-Wu Chen, Masato Chiba, Joy A. Nishime and Florencia A. deLuna
      Drug Metabolism and Disposition April 2000, 28 (4) 460-466;

  4. Lindsay, Thomas J.

    1. Metabolism and Disposition of Moxonidine in Fischer 344 Rats
      Minxia M. He, Trent L. Abraham, Thomas J. Lindsay, Sylvia H. Chay, Boris A. Czeskis and Lisa A. Shipley
      Drug Metabolism and Disposition April 2000, 28 (4) 446-459;

  5. Lord, Raymond S.

    1. Pharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer Patients
      John Greg Slatter, Larry J. Schaaf, James P. Sams, Kenneth L. Feenstra, Mark G. Johnson, Paul A. Bombardt, Karen Sue Cathcart, Michael T. Verburg, Laura K. Pearson, Linda D. Compton, Langdon L. Miller, David S. Baker, Caroline V. Pesheck and Raymond S. Lord
      Drug Metabolism and Disposition April 2000, 28 (4) 423-433;

M

  1. Macdonald, Timothy L.

    1. The Synthesis, In Vitro Reactivity, and Evidence for Formation in Humans of 5-Phenyl-1,3-oxazinane-2,4-dione, a Metabolite of Felbamate
      Charles D. Thompson, Thomas A. Miller, Mary T. Barthen, Christine M. Dieckhaus, R. Duane Sofia and Timothy L. Macdonald
      Drug Metabolism and Disposition April 2000, 28 (4) 434-439;

  2. Madelmont, Jean-Claude

    1. Disposition in Rats of N-Pyridinium-propyl-cyclam,N-Triethylammonium-propyl-cyclam, andN-[Triethylammonium]-3-propyl-[15]ane-N5, Potential Cartilage Imaging Agents
      Jean-Claude Maurizis, Maryse Rapp, Colette Nicolas, Monique Ollier, Michel Verny and Jean-Claude Madelmont
      Drug Metabolism and Disposition April 2000, 28 (4) 418-422;

  3. Marks, Gerald S.

    1. N-Methylprotoporphyrin Is a More Potent Inhibitor of Recombinant Human Than of Recombinant Chicken Ferrochelatase
      Jeremy T. Gamble, Harry A. Dailey and Gerald S. Marks
      Drug Metabolism and Disposition April 2000, 28 (4) 373-375;

  4. Maurizis, Jean-Claude

    1. Disposition in Rats of N-Pyridinium-propyl-cyclam,N-Triethylammonium-propyl-cyclam, andN-[Triethylammonium]-3-propyl-[15]ane-N5, Potential Cartilage Imaging Agents
      Jean-Claude Maurizis, Maryse Rapp, Colette Nicolas, Monique Ollier, Michel Verny and Jean-Claude Madelmont
      Drug Metabolism and Disposition April 2000, 28 (4) 418-422;

  5. Miller, Langdon L.

    1. Pharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer Patients
      John Greg Slatter, Larry J. Schaaf, James P. Sams, Kenneth L. Feenstra, Mark G. Johnson, Paul A. Bombardt, Karen Sue Cathcart, Michael T. Verburg, Laura K. Pearson, Linda D. Compton, Langdon L. Miller, David S. Baker, Caroline V. Pesheck and Raymond S. Lord
      Drug Metabolism and Disposition April 2000, 28 (4) 423-433;

  6. Miller, Thomas A.

    1. The Synthesis, In Vitro Reactivity, and Evidence for Formation in Humans of 5-Phenyl-1,3-oxazinane-2,4-dione, a Metabolite of Felbamate
      Charles D. Thompson, Thomas A. Miller, Mary T. Barthen, Christine M. Dieckhaus, R. Duane Sofia and Timothy L. Macdonald
      Drug Metabolism and Disposition April 2000, 28 (4) 434-439;

  7. Mitra, Ashim K.

    1. Pharmacokinetics, Biliary Excretion, and Tissue Distribution of Novel Anti-HIV Agents, Cosalane and Dihydrocosalane, in Sprague-Dawley Rats
      Kameswara R. Kuchimanchi, Chandrasekhar Udata, Thomas P. Johnston and Ashim K. Mitra
      Drug Metabolism and Disposition April 2000, 28 (4) 403-408;

  8. Mohri, Kiminori

    1. Effects of Long-Term Grapefruit Juice Ingestion on Nifedipine Pharmacokinetics: Induction of Rat Hepatic P-450 by Grapefruit Juice
      Kiminori Mohri, Yoshihiro Uesawa and Ken-ichi Sagawa
      Drug Metabolism and Disposition April 2000, 28 (4) 482-486;

  9. Muro, Kei

    1. Prediction of In Vivo Drug-Drug Interactions Based on Mechanism-based Inhibition from In Vitro Data: Inhibition of 5-Fluorouracil Metabolism by (E)-5-(2-Bromovinyl)uracil
      Shin-ichi Kanamitsu, Kiyomi Ito, Haruhiro Okuda, Kenichiro Ogura, Tadashi Watabe, Kei Muro and Yuichi Sugiyama
      Drug Metabolism and Disposition April 2000, 28 (4) 467-474;

N

  1. Nakajima, Yukiko

    1. Prediction of in Vivo Drug-Drug Interactions between Tolbutamide and Various Sulfonamides in Humans Based on in Vitro Experiments
      Kanji Komatsu, Kiyomi Ito, Yukiko Nakajima, Shin-ichi Kanamitsu, Susumu Imaoka, Yoshihiko Funae, Carol E. Green, Charles A. Tyson, Noriaki Shimada and Yuichi Sugiyama
      Drug Metabolism and Disposition April 2000, 28 (4) 475-481;

  2. Nicolas, Colette

    1. Disposition in Rats of N-Pyridinium-propyl-cyclam,N-Triethylammonium-propyl-cyclam, andN-[Triethylammonium]-3-propyl-[15]ane-N5, Potential Cartilage Imaging Agents
      Jean-Claude Maurizis, Maryse Rapp, Colette Nicolas, Monique Ollier, Michel Verny and Jean-Claude Madelmont
      Drug Metabolism and Disposition April 2000, 28 (4) 418-422;

  3. Nishime, Joy A.

    1. Route-Dependent Nonlinear Pharmacokinetics of a Novel HIV Protease Inhibitor: Involvement of Enzyme Inactivation
      Jiunn H. Lin, I-Wu Chen, Masato Chiba, Joy A. Nishime and Florencia A. deLuna
      Drug Metabolism and Disposition April 2000, 28 (4) 460-466;

O

  1. Ogura, Kenichiro

    1. Prediction of In Vivo Drug-Drug Interactions Based on Mechanism-based Inhibition from In Vitro Data: Inhibition of 5-Fluorouracil Metabolism by (E)-5-(2-Bromovinyl)uracil
      Shin-ichi Kanamitsu, Kiyomi Ito, Haruhiro Okuda, Kenichiro Ogura, Tadashi Watabe, Kei Muro and Yuichi Sugiyama
      Drug Metabolism and Disposition April 2000, 28 (4) 467-474;

  2. Okuda, Haruhiro

    1. Prediction of In Vivo Drug-Drug Interactions Based on Mechanism-based Inhibition from In Vitro Data: Inhibition of 5-Fluorouracil Metabolism by (E)-5-(2-Bromovinyl)uracil
      Shin-ichi Kanamitsu, Kiyomi Ito, Haruhiro Okuda, Kenichiro Ogura, Tadashi Watabe, Kei Muro and Yuichi Sugiyama
      Drug Metabolism and Disposition April 2000, 28 (4) 467-474;

  3. Ollier, Monique

    1. Disposition in Rats of N-Pyridinium-propyl-cyclam,N-Triethylammonium-propyl-cyclam, andN-[Triethylammonium]-3-propyl-[15]ane-N5, Potential Cartilage Imaging Agents
      Jean-Claude Maurizis, Maryse Rapp, Colette Nicolas, Monique Ollier, Michel Verny and Jean-Claude Madelmont
      Drug Metabolism and Disposition April 2000, 28 (4) 418-422;

P

  1. Pearson, Laura K.

    1. Pharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer Patients
      John Greg Slatter, Larry J. Schaaf, James P. Sams, Kenneth L. Feenstra, Mark G. Johnson, Paul A. Bombardt, Karen Sue Cathcart, Michael T. Verburg, Laura K. Pearson, Linda D. Compton, Langdon L. Miller, David S. Baker, Caroline V. Pesheck and Raymond S. Lord
      Drug Metabolism and Disposition April 2000, 28 (4) 423-433;

  2. Pesheck, Caroline V.

    1. Pharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer Patients
      John Greg Slatter, Larry J. Schaaf, James P. Sams, Kenneth L. Feenstra, Mark G. Johnson, Paul A. Bombardt, Karen Sue Cathcart, Michael T. Verburg, Laura K. Pearson, Linda D. Compton, Langdon L. Miller, David S. Baker, Caroline V. Pesheck and Raymond S. Lord
      Drug Metabolism and Disposition April 2000, 28 (4) 423-433;

  3. Puyoou, Franck

    1. Oxidative Metabolism of Bupivacaine into Pipecolylxylidine in Humans Is Mainly Catalyzed by CYP3A
      Manon Gantenbein, Laurence Attolini, Bernard Bruguerolle, Pierre-Henri Villard, Franck Puyoou, Alain Durand, Bruno Lacarelle, Jean Hardwigsen and Yves-Patrice Le-Treut
      Drug Metabolism and Disposition April 2000, 28 (4) 383-385;

R

  1. Rapp, Maryse

    1. Disposition in Rats of N-Pyridinium-propyl-cyclam,N-Triethylammonium-propyl-cyclam, andN-[Triethylammonium]-3-propyl-[15]ane-N5, Potential Cartilage Imaging Agents
      Jean-Claude Maurizis, Maryse Rapp, Colette Nicolas, Monique Ollier, Michel Verny and Jean-Claude Madelmont
      Drug Metabolism and Disposition April 2000, 28 (4) 418-422;

  2. Relling, Mary V.

    1. Human Cytochrome P450 Maximal Activities In Pediatric versus Adult Liver
      Javier G. Blanco, Patricia L. Harrison, William E. Evans and Mary V. Relling
      Drug Metabolism and Disposition April 2000, 28 (4) 379-382;

S

  1. Sagawa, Ken-ichi

    1. Effects of Long-Term Grapefruit Juice Ingestion on Nifedipine Pharmacokinetics: Induction of Rat Hepatic P-450 by Grapefruit Juice
      Kiminori Mohri, Yoshihiro Uesawa and Ken-ichi Sagawa
      Drug Metabolism and Disposition April 2000, 28 (4) 482-486;

  2. Sams, James P.

    1. Pharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer Patients
      John Greg Slatter, Larry J. Schaaf, James P. Sams, Kenneth L. Feenstra, Mark G. Johnson, Paul A. Bombardt, Karen Sue Cathcart, Michael T. Verburg, Laura K. Pearson, Linda D. Compton, Langdon L. Miller, David S. Baker, Caroline V. Pesheck and Raymond S. Lord
      Drug Metabolism and Disposition April 2000, 28 (4) 423-433;

  3. Schaaf, Larry J.

    1. Pharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer Patients
      John Greg Slatter, Larry J. Schaaf, James P. Sams, Kenneth L. Feenstra, Mark G. Johnson, Paul A. Bombardt, Karen Sue Cathcart, Michael T. Verburg, Laura K. Pearson, Linda D. Compton, Langdon L. Miller, David S. Baker, Caroline V. Pesheck and Raymond S. Lord
      Drug Metabolism and Disposition April 2000, 28 (4) 423-433;

  4. Sevoz, Cendrine

    1. Thioesterification of 2-Arylpropionic Acids by Recombinant Acyl-Coenzyme A Synthetases (ACS1 and ACS2)
      Cendrine Sevoz, Etienne Benoit and Thierry Buronfosse
      Drug Metabolism and Disposition April 2000, 28 (4) 398-402;

  5. Shader, Richard I.

    1. In Vitro Biotransformation of Sildenafil (Viagra): Identification of Human Cytochromes and Potential Drug Interactions
      Jill S. Warrington, Richard I. Shader, Lisa L. von Moltke and David J. Greenblatt
      Drug Metabolism and Disposition April 2000, 28 (4) 392-397;

  6. Shaw, Kiana L.

    1. The N-Acetylation of Arsanilic Acid In Vitro by Mammalian Enzymes
      Gladys S. Bayse, Laide A. Jinadu, Kiana L. Shaw and Kelita L. Wiley
      Drug Metabolism and Disposition April 2000, 28 (4) 487-492;

  7. Shimada, Noriaki

    1. Prediction of in Vivo Drug-Drug Interactions between Tolbutamide and Various Sulfonamides in Humans Based on in Vitro Experiments
      Kanji Komatsu, Kiyomi Ito, Yukiko Nakajima, Shin-ichi Kanamitsu, Susumu Imaoka, Yoshihiko Funae, Carol E. Green, Charles A. Tyson, Noriaki Shimada and Yuichi Sugiyama
      Drug Metabolism and Disposition April 2000, 28 (4) 475-481;

  8. Shipley, Lisa A.

    1. Metabolism and Disposition of Moxonidine in Fischer 344 Rats
      Minxia M. He, Trent L. Abraham, Thomas J. Lindsay, Sylvia H. Chay, Boris A. Czeskis and Lisa A. Shipley
      Drug Metabolism and Disposition April 2000, 28 (4) 446-459;

  9. Slatter, John Greg

    1. Pharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer Patients
      John Greg Slatter, Larry J. Schaaf, James P. Sams, Kenneth L. Feenstra, Mark G. Johnson, Paul A. Bombardt, Karen Sue Cathcart, Michael T. Verburg, Laura K. Pearson, Linda D. Compton, Langdon L. Miller, David S. Baker, Caroline V. Pesheck and Raymond S. Lord
      Drug Metabolism and Disposition April 2000, 28 (4) 423-433;

  10. Sofia, R. Duane

    1. The Synthesis, In Vitro Reactivity, and Evidence for Formation in Humans of 5-Phenyl-1,3-oxazinane-2,4-dione, a Metabolite of Felbamate
      Charles D. Thompson, Thomas A. Miller, Mary T. Barthen, Christine M. Dieckhaus, R. Duane Sofia and Timothy L. Macdonald
      Drug Metabolism and Disposition April 2000, 28 (4) 434-439;

  11. Sugiyama, Yuichi

    1. Prediction of In Vivo Drug-Drug Interactions Based on Mechanism-based Inhibition from In Vitro Data: Inhibition of 5-Fluorouracil Metabolism by (E)-5-(2-Bromovinyl)uracil
      Shin-ichi Kanamitsu, Kiyomi Ito, Haruhiro Okuda, Kenichiro Ogura, Tadashi Watabe, Kei Muro and Yuichi Sugiyama
      Drug Metabolism and Disposition April 2000, 28 (4) 467-474;
    2. Prediction of in Vivo Drug-Drug Interactions between Tolbutamide and Various Sulfonamides in Humans Based on in Vitro Experiments
      Kanji Komatsu, Kiyomi Ito, Yukiko Nakajima, Shin-ichi Kanamitsu, Susumu Imaoka, Yoshihiko Funae, Carol E. Green, Charles A. Tyson, Noriaki Shimada and Yuichi Sugiyama
      Drug Metabolism and Disposition April 2000, 28 (4) 475-481;

  12. Suzuki, Hisashi

    1. Studies on the Cytochrome P450 (CYP)-Mediated Metabolic Properties of Miocamycin: Evaluation of the Possibility of a Metabolic Intermediate Complex Formation with CYP, and Identification of the Human CYP Isoforms
      Mie Kasahara, Hisashi Suzuki and Izumi Komiya
      Drug Metabolism and Disposition April 2000, 28 (4) 409-417;

T

  1. Thompson, Charles D.

    1. The Synthesis, In Vitro Reactivity, and Evidence for Formation in Humans of 5-Phenyl-1,3-oxazinane-2,4-dione, a Metabolite of Felbamate
      Charles D. Thompson, Thomas A. Miller, Mary T. Barthen, Christine M. Dieckhaus, R. Duane Sofia and Timothy L. Macdonald
      Drug Metabolism and Disposition April 2000, 28 (4) 434-439;

  2. Tyson, Charles A.

    1. Prediction of in Vivo Drug-Drug Interactions between Tolbutamide and Various Sulfonamides in Humans Based on in Vitro Experiments
      Kanji Komatsu, Kiyomi Ito, Yukiko Nakajima, Shin-ichi Kanamitsu, Susumu Imaoka, Yoshihiko Funae, Carol E. Green, Charles A. Tyson, Noriaki Shimada and Yuichi Sugiyama
      Drug Metabolism and Disposition April 2000, 28 (4) 475-481;

U

  1. Udata, Chandrasekhar

    1. Pharmacokinetics, Biliary Excretion, and Tissue Distribution of Novel Anti-HIV Agents, Cosalane and Dihydrocosalane, in Sprague-Dawley Rats
      Kameswara R. Kuchimanchi, Chandrasekhar Udata, Thomas P. Johnston and Ashim K. Mitra
      Drug Metabolism and Disposition April 2000, 28 (4) 403-408;

  2. Uesawa, Yoshihiro

    1. Effects of Long-Term Grapefruit Juice Ingestion on Nifedipine Pharmacokinetics: Induction of Rat Hepatic P-450 by Grapefruit Juice
      Kiminori Mohri, Yoshihiro Uesawa and Ken-ichi Sagawa
      Drug Metabolism and Disposition April 2000, 28 (4) 482-486;

  3. Uttamsingh, Viuita

    1. Porcine Kidney Microsomal Cysteine S-ConjugateN-Acetyltransferase-CatalyzedN-Acetylation of Haloalkene-Derived CysteineS-Conjugates
      Torsten Kraus, Viuita Uttamsingh, M.W. Anders and Sabine Wolf
      Drug Metabolism and Disposition April 2000, 28 (4) 440-445;

V

  1. Verburg, Michael T.

    1. Pharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer Patients
      John Greg Slatter, Larry J. Schaaf, James P. Sams, Kenneth L. Feenstra, Mark G. Johnson, Paul A. Bombardt, Karen Sue Cathcart, Michael T. Verburg, Laura K. Pearson, Linda D. Compton, Langdon L. Miller, David S. Baker, Caroline V. Pesheck and Raymond S. Lord
      Drug Metabolism and Disposition April 2000, 28 (4) 423-433;

  2. Verny, Michel

    1. Disposition in Rats of N-Pyridinium-propyl-cyclam,N-Triethylammonium-propyl-cyclam, andN-[Triethylammonium]-3-propyl-[15]ane-N5, Potential Cartilage Imaging Agents
      Jean-Claude Maurizis, Maryse Rapp, Colette Nicolas, Monique Ollier, Michel Verny and Jean-Claude Madelmont
      Drug Metabolism and Disposition April 2000, 28 (4) 418-422;

  3. Villard, Pierre-Henri

    1. Oxidative Metabolism of Bupivacaine into Pipecolylxylidine in Humans Is Mainly Catalyzed by CYP3A
      Manon Gantenbein, Laurence Attolini, Bernard Bruguerolle, Pierre-Henri Villard, Franck Puyoou, Alain Durand, Bruno Lacarelle, Jean Hardwigsen and Yves-Patrice Le-Treut
      Drug Metabolism and Disposition April 2000, 28 (4) 383-385;

  4. von Moltke, Lisa L.

    1. In Vitro Biotransformation of Sildenafil (Viagra): Identification of Human Cytochromes and Potential Drug Interactions
      Jill S. Warrington, Richard I. Shader, Lisa L. von Moltke and David J. Greenblatt
      Drug Metabolism and Disposition April 2000, 28 (4) 392-397;

W

  1. Warrington, Jill S.

    1. In Vitro Biotransformation of Sildenafil (Viagra): Identification of Human Cytochromes and Potential Drug Interactions
      Jill S. Warrington, Richard I. Shader, Lisa L. von Moltke and David J. Greenblatt
      Drug Metabolism and Disposition April 2000, 28 (4) 392-397;

  2. Watabe, Tadashi

    1. Prediction of In Vivo Drug-Drug Interactions Based on Mechanism-based Inhibition from In Vitro Data: Inhibition of 5-Fluorouracil Metabolism by (E)-5-(2-Bromovinyl)uracil
      Shin-ichi Kanamitsu, Kiyomi Ito, Haruhiro Okuda, Kenichiro Ogura, Tadashi Watabe, Kei Muro and Yuichi Sugiyama
      Drug Metabolism and Disposition April 2000, 28 (4) 467-474;

  3. Watt, Katherine C.

    1. Species Differences in The Regio- and Stereoselectivity of 1-Nitronaphthalene Metabolism
      Katherine C. Watt and Alan R. Buckpitt
      Drug Metabolism and Disposition April 2000, 28 (4) 376-378;

  4. Wiley, Kelita L.

    1. The N-Acetylation of Arsanilic Acid In Vitro by Mammalian Enzymes
      Gladys S. Bayse, Laide A. Jinadu, Kiana L. Shaw and Kelita L. Wiley
      Drug Metabolism and Disposition April 2000, 28 (4) 487-492;

  5. Wolf, Sabine

    1. Porcine Kidney Microsomal Cysteine S-ConjugateN-Acetyltransferase-CatalyzedN-Acetylation of Haloalkene-Derived CysteineS-Conjugates
      Torsten Kraus, Viuita Uttamsingh, M.W. Anders and Sabine Wolf
      Drug Metabolism and Disposition April 2000, 28 (4) 440-445;
Back to top

In this issue